Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Manufacture Advanced Medicine, Supply Chain

Video Interview: Tamas Masztis

Tamas Masztis, Kite

What are the biggest trends in cell and gene therapy? We recently interviewed a few speakers from Advanced Therapies Integrates to get their views!What are the biggest trends in cell and gene therapy? We recently interviewed a few speakers from Advanced Therapies Integrates to get their views!

Here, we speak with Tamas Masztis, Senior Director, Cell Therapy Supply Chain for Europe, Kite, a Gilead Company. Tamas built one of the first cell therapy supply chains for Europe and Israel. The successful implementation of this complex, centralized end-to-end supply chain involving the transportation of patient cells has been critical to launching Kite’s cell therapies in 24 countries in the region to date.

In part 1 of this interview, we ask Tamas what inspired his interest in sourcing and supply chains, and find out more about his role at Kite.

In part 2, we delve into the wider cell and gene therapy space, including supply chain challenges and the impact of the pandemic.

Receive content, products, events as well as relevant industry updates from The Medicine Maker and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register